• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study.

作者信息

de Boer Rudolf A, Azizi Michel, Danser Ah Jan, Nguyen Geneviève, Nussberger Jürg, Ruilope Luis M, Schmieder Roland E, Volpe Massimo

机构信息

Department of Cardiology, University Medical Center Groningen, University of Groningen, the Netherlands.

出版信息

J Renin Angiotensin Aldosterone Syst. 2012 Sep;13(3):409-12. doi: 10.1177/1470320312455271.

DOI:10.1177/1470320312455271
PMID:22930101
Abstract
摘要

相似文献

1
Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study.双重肾素-血管紧张素-醛固酮系统抑制：鉴于ALTITUDE研究的最新进展及影响
J Renin Angiotensin Aldosterone Syst. 2012 Sep;13(3):409-12. doi: 10.1177/1470320312455271.
2
ALTITUDE trial and dual RAS blockade: the alluring but soft science of the surrogate end point.海拔试验与双重肾素-血管紧张素系统阻断：替代终点这一诱人却缺乏实质内容的科学。
Am J Med. 2013 Mar;126(3):e1-3. doi: 10.1016/j.amjmed.2012.07.006. Epub 2013 Jan 16.
3
Which strategy in inhibition of the renin-angiotensin system is the most efficient for heart failure?在抑制肾素-血管紧张素系统方面，哪种策略对心力衰竭最为有效？
J Renin Angiotensin Aldosterone Syst. 2008 Sep;9(3):184-5. doi: 10.1177/1470320308097418.
4
[Direct renin inhibition: a new and promising treatment principle in heart failure?].直接肾素抑制：心力衰竭治疗中一种新的且有前景的治疗原则？
Dtsch Med Wochenschr. 2009 Apr;134(15):759-62. doi: 10.1055/s-0029-1220227. Epub 2009 Apr 1.
5
[Advantages and limitations of renin inhibition with aliskiren].[阿利吉仑肾素抑制作用的优势与局限]
Ann Pharm Fr. 2011 May;69(3):142-50. doi: 10.1016/j.pharma.2011.02.002. Epub 2011 Apr 21.
6
Challenges to Data Monitoring Committees When Regulatory Authorities Intervene.监管机构干预时数据监测委员会面临的挑战。
N Engl J Med. 2016 Apr 21;374(16):1580-4. doi: 10.1056/NEJMsb1601674. Epub 2016 Apr 4.
7
Losing ALTITUDE? How should ASTRONAUT launch into ATMOSPHERE.正在降低高度？宇航员应如何进入大气层？
Eur J Heart Fail. 2013 Nov;15(11):1205-7. doi: 10.1093/eurjhf/hft133. Epub 2013 Aug 29.
8
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.阿利吉仑治疗2型糖尿病的心脏肾脏终点试验（ALTITUDE）：原理与研究设计
Nephrol Dial Transplant. 2009 May;24(5):1663-71. doi: 10.1093/ndt/gfn721. Epub 2009 Jan 14.
9
Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.阿利吉仑：一种新型肾素-血管紧张素-醛固酮系统活性抑制剂。
Minerva Endocrinol. 2009 Dec;34(4):333-8.
10
Anti-angiotensin therapy: new perspectives.抗血管紧张素疗法：新视角
Cardiol Clin. 2007 Nov;25(4):573-80; vi-vii. doi: 10.1016/j.ccl.2007.09.003.

引用本文的文献

1
Effects of dual inhibition of renin-angiotensin-aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits.双重抑制肾素-血管紧张素-醛固酮系统对心血管和肾脏结局的影响：平衡风险和获益。
Intern Emerg Med. 2020 Apr;15(3):373-379. doi: 10.1007/s11739-019-02257-3. Epub 2019 Dec 21.
2
Attitudes and preferences for the clinical management of hypertension and hypertension-related cerebrovascular disease in the general practice: results of the Italian hypertension and brain survey.全科医疗中高血压及高血压相关脑血管疾病临床管理的态度与偏好：意大利高血压与脑部调查结果
Clin Hypertens. 2017 May 15;23:10. doi: 10.1186/s40885-017-0066-0. eCollection 2017.
3
Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial.
米诺环素对糖尿病肾病患者尿白蛋白、白细胞介素-6和骨保护素的影响：一项随机对照试验
PLoS One. 2016 Mar 28;11(3):e0152357. doi: 10.1371/journal.pone.0152357. eCollection 2016.
4
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders.联合血管紧张素受体调节在心血管代谢紊乱管理中的应用
Drugs. 2016 Jan;76(1):1-12. doi: 10.1007/s40265-015-0509-4.
5
Understanding and treating hypertension in diabetic populations.了解和治疗糖尿病患者的高血压
Cardiovasc Diagn Ther. 2015 Oct;5(5):353-63. doi: 10.3978/j.issn.2223-3652.2015.06.02.
6
Attitudes and preferences for the clinical management of patients with hypertension and hypertension with chronic obstructive pulmonary disease in Italy: main results of a survey questionnaire.意大利高血压患者及合并慢性阻塞性肺疾病的高血压患者临床管理的态度和偏好：调查问卷主要结果
Intern Emerg Med. 2015 Dec;10(8):943-54. doi: 10.1007/s11739-015-1256-y. Epub 2015 May 19.
7
Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.与单独阻断 AT1 受体相比，最佳的 AT1 受体-脑啡肽酶抑制在高血压大鼠中具有更优的心脏保护作用。
Kidney Int. 2015 Jul;88(1):109-20. doi: 10.1038/ki.2015.107. Epub 2015 Apr 1.
8
Dual renin-angiotensin-aldosterone blockade: promises and pitfalls.双重肾素-血管紧张素-醛固酮阻断：前景与隐患
Curr Hypertens Rep. 2015 Jan;17(1):511. doi: 10.1007/s11906-014-0511-3.
9
Targeting the renin-angiotensin-aldosterone system in heart failure.心力衰竭中肾素-血管紧张素-醛固酮系统的靶向治疗。
Nat Rev Cardiol. 2013 Mar;10(3):125-34. doi: 10.1038/nrcardio.2012.196. Epub 2013 Jan 15.
10
Key developments in renin-angiotensin-aldosterone system inhibition.肾素-血管紧张素-醛固酮系统抑制的关键进展。
Nat Rev Nephrol. 2013 Jan;9(1):26-36. doi: 10.1038/nrneph.2012.249. Epub 2012 Nov 20.